Delis J. Mattei-Lopez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Delis J. Mattei-Lopez has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Cristian Koepfli
University of Notre Dame, Notre Dame, USA
2 shared publications - Douglas A. Shoue
Department of Biological Sciences, University of Notre Dame, Notre Dame, IN 46556, USA
2 shared publications - Juan P. Gonzalez
Department of Biological Sciences, University of Notre Dame, Notre Dame, IN 46556, USA
2 shared publications - Mary Ann McDowell
Department of Biological Sciences, Eck Institute for Global Health, University of Notre Dame, Notre Dame, USA
2 shared publications - Mohanna Sadat Sajjadi Oskouei
Department of Biological Sciences, University of Notre Dame, Notre Dame, IN 46556, USA
2 shared publications - Ashley Elizabeth Shields
Oak Ridge National Laboratory (ORNL), Oak Ridge, TN (United States)
1 shared publication
Latest Publications
- Open Access
- 3 October 2026
- Published by MDPI AG in Tropical Medicine and Infectious Disease
- Vol. 11 (10) , 281
Extracellular Vesicle-Derived Spliced Leader RNA as a Minimally Invasive Molecular Biomarker for Leishmaniasis Detection
Leishmaniasis continues to be a major neglected tropical disease, particularly in endemic areas where reliable diagnosis remains challenging. Many existing diagnostic methods are invasive, lack sufficient sensitivity, or require equipment and expertise that may not be available in resource-limited settings. Parasite-derived spliced leader (SL) RNA has recently gained attention as a promising molecular marker because it may enable the sensitive detection of viable Leishmania parasites and help track changes in infection over time. Extracellular vesicles (EVs) are also of growing interest because they protect and transport stable biomolecules that may provide valuable diagnostic information and influence interactions between the parasite and its host. In this proof-of-concept study, we evaluated the feasibility of detecting Leishmania-derived SL-RNA in EV-enriched preparations from experimental leishmaniasis model systems. EV-enriched preparations were isolated from parasite-conditioned media (PCM), infected THP-1 macrophage (I-MP) cell-conditioned medium (CCM), and serum from experimentally infected mice using a precipitation method. As a complementary isolation approach, additional preparations were isolated from PCM by ultracentrifugation. An aliquot of each preparation was analyzed by nanoparticle tracking analysis to determine particle size and concentration, and the remaining portion was used for RNA extraction. RNA was reverse transcribed into cDNA and analyzed for SL-RNA amplification using quantitative polymerase chain reaction (qPCR). SL-RNA amplification was successfully detected in PCM, I-MP CCM, and serum from experimentally infected mice, while uninfected controls showed no specific amplification. These findings were independently confirmed via ddPCR analysis. Notably, EV-enriched preparations from infected mice yielded a stronger SL-RNA signal than serum alone, highlighting the diagnostic potential of targeting SL-RNA in EV-enriched human clinical samples, particularly in low-burden infections. Although these findings support the feasibility of EV-associated SL-RNA as a molecular biomarker for Leishmania infection, clinical validation with human samples is required.
- 3 October 2026
- Published by MDPI AG in Tropical Medicine and Infectious Disease
- Vol. 11 (10) , 281
Open AccessExtracellular Vesicle-Derived Spliced Leader RNA as a Minimally Invasive Molecular Biomarker for Leishmaniasis Detection
Leishmaniasis continues to be a major neglected tropical disease, particularly in endemic areas where reliable diagnosis remains challenging. Many existing diagnostic methods are invasive, lack sufficient sensitivity, or require equipment and expertise that may not be available in resource-limited settings. Parasite-derived spliced leader (SL) RNA has recently gained attention as a promising molecular marker because it may enable the sensitive detection of viable Leishmania parasites and help track changes in infection over time. Extracellular vesicles (EVs) are also of growing interest because they protect and transport stable biomolecules that may provide valuable diagnostic information and influence interactions between the parasite and its host. In this proof-of-concept study, we evaluated the feasibility of detecting Leishmania-derived SL-RNA in EV-enriched preparations from experimental leishmaniasis model systems. EV-enriched preparations were isolated from parasite-conditioned media (PCM), infected THP-1 macrophage (I-MP) cell-conditioned medium (CCM), and serum from experimentally infected mice using a precipitation method. As a complementary isolation approach, additional preparations were isolated from PCM by ultracentrifugation. An aliquot of each preparation was analyzed by nanoparticle tracking analysis to determine particle size and concentration, and the remaining portion was used for RNA extraction. RNA was reverse transcribed into cDNA and analyzed for SL-RNA amplification using quantitative polymerase chain reaction (qPCR). SL-RNA amplification was successfully detected in PCM, I-MP CCM, and serum from experimentally infected mice, while uninfected controls showed no specific amplification. These findings were independently confirmed via ddPCR analysis. Notably, EV-enriched preparations from infected mice yielded a stronger SL-RNA signal than serum alone, highlighting the diagnostic potential of targeting SL-RNA in EV-enriched human clinical samples, particularly in low-burden infections. Although these findings support the feasibility of EV-associated SL-RNA as a molecular biomarker for Leishmania infection, clinical validation with human samples is required.
- Open Access
- 6 August 2026
- Published by MDPI AG in Preprints.org
Extracellular Vesicle-Derived Spliced Leader RNA as a Minimally Invasive Molecular Biomarker for Leishmaniasis Detection
Leishmaniasis continues to be a major neglected tropical disease, particularly in endemic areas where reliable diagnosis remains challenging. Many existing diagnostic methods are invasive, lack sufficient sensitivity, or require equipment and expertise that may not be available in resource-limited settings. Parasite-derived spliced leader (SL) RNA has recently gained attention as a promising molecular marker because it may enable the sensitive detection of viable Leishmania parasites and help track changes in infection over time. Extracellular vesicles (EVs) are also of growing interest because they protect and transport stable biomolecules that may provide valuable diagnostic information and influence interactions between the parasite and its host. In this study, we evaluated the feasibility of detecting Leishmania-derived SL-RNA within EV-associated samples. EVs were isolated from parasite-conditioned media (PCM) and infected THP-1 macrophage (I-MP) cell-conditioned medium (CCM), followed by nanoparticle tracking analysis for EV characterization. RNA was extracted from EV preparations, reverse transcribed into cDNA and analyzed for SL-RNA amplification using quantitative polymerase chain reaction (qPCR) and droplet digital PCR (ddPCR) approaches. Successful amplification of SL-RNA was detected in PCM and I-MP CCM EV samples, whereas uninfected controls showed no specific amplification. ddPCR analysis demonstrated sensitive detection across infected samples which supports the potential utility of this approach for low-abundance target detection. These findings support the feasibility of EV-associated SL-RNA as a molecular biomarker for Leishmania infection.
- 6 August 2026
- Published by MDPI AG in Preprints.org
Open AccessExtracellular Vesicle-Derived Spliced Leader RNA as a Minimally Invasive Molecular Biomarker for Leishmaniasis Detection
Leishmaniasis continues to be a major neglected tropical disease, particularly in endemic areas where reliable diagnosis remains challenging. Many existing diagnostic methods are invasive, lack sufficient sensitivity, or require equipment and expertise that may not be available in resource-limited settings. Parasite-derived spliced leader (SL) RNA has recently gained attention as a promising molecular marker because it may enable the sensitive detection of viable Leishmania parasites and help track changes in infection over time. Extracellular vesicles (EVs) are also of growing interest because they protect and transport stable biomolecules that may provide valuable diagnostic information and influence interactions between the parasite and its host. In this study, we evaluated the feasibility of detecting Leishmania-derived SL-RNA within EV-associated samples. EVs were isolated from parasite-conditioned media (PCM) and infected THP-1 macrophage (I-MP) cell-conditioned medium (CCM), followed by nanoparticle tracking analysis for EV characterization. RNA was extracted from EV preparations, reverse transcribed into cDNA and analyzed for SL-RNA amplification using quantitative polymerase chain reaction (qPCR) and droplet digital PCR (ddPCR) approaches. Successful amplification of SL-RNA was detected in PCM and I-MP CCM EV samples, whereas uninfected controls showed no specific amplification. ddPCR analysis demonstrated sensitive detection across infected samples which supports the potential utility of this approach for low-abundance target detection. These findings support the feasibility of EV-associated SL-RNA as a molecular biomarker for Leishmania infection.
- 1 July 2021
- Published by Elsevier in Computational Materials Science
- Vol. 195
Reviewing computational studies of defect formation and behaviors in carbon fiber structural units
- 1 July 2021
- Published by Elsevier in Computational Materials Science
- Vol. 195
Reviewing computational studies of defect formation and behaviors in carbon fiber structural units